Current Research into Cures for Type-1 Diabetes
News and updates on potential cures for type-1 diabetes, that are in human (or clinical) trials.
Pages
(Move to ...)
Home
Introduction to this Blog
About This Blog
Common Words, Phrases, and Ideas in this Blog
Defining Successful Studies
▼
Showing posts with label
CD3
.
Show all posts
Showing posts with label
CD3
.
Show all posts
Thursday, September 19, 2019
Teplizumab Phase-II Results For Prevention And Starts A Phase-III On Honeymooners
›
As with previous years, the American Diabetes Association's annual scientific meeting is mostly about type-2 diabetes, and even the type...
Friday, September 13, 2013
Results from a Phase-II Trial of Teplizumab in Honeymooners
›
This blog posting covers the results from a phase-II clinical trial of a drug called Teplizumab. This trial ran from 2005-2011 and was publ...
Monday, March 14, 2011
Tolerx's Otelixizumab Fails in Phase-III Trial
›
Otelixizumab (Tolerx / GlaxoSmithKline) Fails Phase-III Trial The official quote is "did not meet the primary efficacy endpoint"...
Saturday, June 20, 2009
News from MacroGenics on Teplizumab
›
Two pieces of news from MacroGenics: First, their phase-II human trial of teplizumab (called PROTEGE ) is fully enrolled. Second, they are s...
3 comments:
Monday, May 25, 2009
NovImmune to enter Phase-II with NI-0401 (Another CD3 targeted drug)
›
It looks like NovImmune (a Swiss company) will start phase-II trials of NI-0401, a CD3 targeted drug "this quarter" and hope to ha...
›
Home
View web version
